Loading…
20,252 grants found
Showing 1,741 – 1,760 of 20,252 grants
Project Summary/Abstract The Institute for Health Promotion Research (IHPR) and the Mays Cancer Center, an NCI-designated cancer center at UT Health San Antonio, partner closely to...
ABSTRACT Relative to matched normal tissue, recent large scale sequencing efforts indicate that colorectal cancer (CRC) tumors are specifically enriched in loss of function mutatio...
ABSTRACT Relative to matched normal tissue, recent large scale sequencing efforts indicate that colorectal cancer (CRC) tumors are specifically enriched in loss of function mutatio...
Summary Standard-of-care treatments for most sarcomas and other childhood cancers include high-doses of anthracyclines, in particular doxorubicin (DOXO). DOXO causes irreparable da...
Project Summary Targeted covalent inhibitors have empowered the potent and selective targeting of driver oncogenes in cancer. Between 2011 and 2021, 16 new covalent drugs (12 with...
PROJECT SUMMARY Although dysregulated gene transcription is a major contributing factor in cancer, the development of drugs interfering with general transcription remains a challen...
Positron emission tomography (PET), a sensitive functional imaging technique, holds potential for diagnosing and monitoring medical conditions. Its use in pediatric oncology is hin...
PROJECT SUMMARY Clear cell ovarian cancer (CCOC) is one of the most challenging subtypes of ovarian cancer (OVCA) to treat, as it is resistant to standard chemotherapy and is assoc...
PROJECT SUMMARY/ABSTRACT Limitations of checkpoint inhibitor cancer treatment include precipitation of autoimmunity and resistance to immunotherapy. For some cancers, notably prost...
PROJECT SUMMARY/ABSTRACT Although evidence-based cancer screening protocols exist for several common cancer types, an estimated 70% of cancer deaths are due to cancers for which no...
Project Summary Multi-cancer detection (MCD) tests, which evaluate cell-free DNA and other biological components with a single blood draw, are a new frontier in cancer screening, p...
More than 30% of children diagnosed with acute myeloid leukemia (AML) relapse after initial treatment, creating an urgent need for new treatment options.T-cell receptor (TCR) based...
Diffuse intrinsic pontine glioma (DIPG) is a rare, universally fatal childhood brainstem tumor, striking about 150-300 children in the US with a median survival of only 9-11 months...
The five year survival of children with refractory or relapsed neuroblastoma (NBL), often with MYCN amplified tumors, is only about 10%, and the outcome for this subset of patients...
This proposal seeks to develop a novel therapeutic approach for recurrent or metastatic adrenocortical carcinoma (ACC), a rare and aggressive malignancy of the adrenal cortex. The...
Acute lymphocytic leukemia, a blood cancer, is most common among children under five and is treated with chemotherapy.Neutropenic enterocolitis (NEC) is a life-threatening complica...
This proposal aims to advance drug repurposing for rare cancers by utilizing cutting-edge computational approaches. The long-term objectives are to discover effective treatments fo...
Oral cancer remains a life-threatening disease with 11,580 deaths in the US each year. Surgery provides the best chance of survival and is the preferred treatment option for oral c...
Many cancers exhibit aberrant overexpression of developmental lineage-specific transcription factors.In this project we investigate the potential of exploiting oncogenic overexpres...
PROJECT SUMMARY/ABSTRACT Chromosomal translocations occur in nearly all human lymphoid neoplasms, many the result of aberrant repair of DNA double-stand breaks (DSBs) generated in...